​

​

December 31, 2025

​

December 31, 2024

​

  ​ ​ ​

$  

  ​ ​ ​

$  

Salaries and management fees

​

3,359

​

2,687

Discovery expenses

​

682

​

698

Preclinical expenses

​

2,160

​

5,420

Chemistry, manufacturing controls

​

1,117

​

2,495

Clinical expenses

​

9,600

​

2,459

Stock-based compensation

​

1,508

​

600

Total research and development expenses

​

18,426

​

14,359

​

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

​

  ​ ​ ​

$

  ​ ​ ​

$

Salaries and management fees

​

3,337

​

2,723

Professional fees

​

2,374

​

1,688

Other operating expenses

​

590

​

572

Stock-based compensation

​

1,727

​

1,041

Depreciation

​

5

​

15

Total general and administrative expenses

​

8,033

​

6,039